Global Malaria Treatment Market is Growing with 6.1% CAGR in the Forecast Period of 2020 to 2027

Global Malaria Treatment Market is growing with factors such as growing prevalence and disease burden of malaria. Additionally pandemic outbreak of coronavirus infectious disease (COVID-19) acts as a major factor for the growth of the market. Humid climatic conditions and very efficient mosquito (Anopheles Gambiae Complex) in certain parts of Africa has also given a boom to the malaria treatment market.

Product launch of various malaria treatment products has propelled the demand of the market. However, adverse reaction associated with malaria treatment medication have decreased the demand of the market.

Global Malaria Treatment Market Scenario                              

According to Data Bridge Market Research, the market for global malaria treatment in Middle East & Africa has the highest market share followed by Asia-Pacific and South America. Market leader is AJANTA PHARMA, which accounts an estimated market share of approximately 11.20% in the market. The company has gained outstanding sale by providing huge product portfolio for malaria treatment market.

Malaria Treatment Market

Trends Impacting the Market

Now the question is which other regions AJANTA PHARMA, Novartis AG, Cipla Inc. are targeting? Data Bridge Market Research has forecasted a large growth in Middle East and Africa Malaria treatment market and the market leaders targeting Nigeria and Democratic Republic of the Congo to be their next pocket revenue for 2020.

The malaria treatment market is becoming more competitive with companies like AJANTA PHARMA, Novartis AG, Cipla Inc., and Strides Pharma Science Limited. These are the top dominating companies in malaria treatment market and are launching more new products in the market. The data bridge market research new reports highlight the major growth factors and opportunities in the global malaria treatment market.

For more analysis on the malaria treatment market request for a briefing with our analysts

New Market Developments in 2019

  • In November 2019, Mylan-Upjohn combination of Mylan N.V. and Pfizer announced Viatris as the new company. Resulting, this acquisition has expanding expanded access to medicines across the world as well as leading by innovating innovation to meet patient needs. Which indicating indicates future revenue growth of Mylan N.V.

Scope of the global Malaria treatment market

The malaria treatment market is segmented on the basis of countries into the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Nigeria, Democratic Republic of the Congo, Uganda, Mozambique, Niger, Côte d’Ivoire, South Africa, Egypt, Saudi Arabia, U.A.E., Israel, Kuwait and Rest of Middle East and Africa.

  • All country based analysis of the malaria treatment market is further analyzed into seven notable segments which are on the basis of agent, type, treatment type, drug type, route of administration, end user and distribution channel. On the basis of agent, the malaria treatment market is segmented into plasmodium falciparum, P. vivax, P. ovale, P. malariae and P. knowlelsi. On the basis of type, the malaria treatment market is segmented into medication and vaccination.  On the basis of treatment type, the malaria treatment market is segmented into the suppressive treatment and radical treatment. On the basis of drug type, the malaria treatment market is segmented into branded and generics. On the basis of route of administration, the malaria treatment market is segmented into oral and parentral. On the basis of end user, the malaria treatment market is segmented into hospitals, specialty clinics, home healthcare and others. On the basis of distribution channel, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies and online pharmacies.

To know more about the study

Key Pointers Covered in Global Malaria treatment Market Industry Trends and Forecast to 2027

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries
  • Market value and over view of Malaria treatment market
  • Company profiling of top eight players of Malaria treatment market

Key Market Competitors Covered in the Report

  • Actiza Pharmaceutical Private Limited
  • AdvaCare Pharma
  • Amneal Pharmaceuticals LLC.
  • Hikma Pharmaceuticals PLC
  • Ipca Laboratories Ltd.
  • Mylan N.V.
  • Sun Pharmaceutical Industries Ltd.
  • Zydus Cadila
  • Cipla Inc.
  • Bliss GVS Pharma Ltd.
  • GeoVax
  • MMV
  • Novartis AG
  • Sumaya Biotech
  • Taj Pharmaceuticals Limited
  • VLP Therapeutics
  • Lupin Pharmaceuticals, Inc. (a subsidiary of LUPIN)
  • Strides Pharma Science Limited

Above are the key players covered in the report, to know about more and exhaustive list of malaria treatment companies’, contact us

Research Methodology: Global Malaria Treatment Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Manufacturer, Healthcare Industry, Dermatologists, Scientists, Research Laboratories
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@